Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378191182> ?p ?o ?g. }
- W4378191182 endingPage "109256" @default.
- W4378191182 startingPage "109256" @default.
- W4378191182 abstract "Seizure control in women with epilepsy (WWE) during pregnancy is a vital concern. The aim of this study was to compare changes in seizure frequency and anti-seizure medication (ASM ) therapy in WWE in a real-world setting over three epochs (prepregnancy, pregnancy, and postpregnancy). We screened WWE who were pregnant between 1 January 2010 and 31 December 2020 from the epilepsy follow-up registry database of a tertiary hospital in China. We reviewed and collected follow-up data for the following time periods: 12 months before pregnancy (epoch 1), throughout pregnancy and the first 6 weeks postpartum (epoch 2), and from 6 weeks to 12 months postpartum (epoch 3). Seizures were classified into two categories: tonic‒clonic/focal to bilateral tonic‒clonic seizures and non-tonic‒clonic seizures. The main indicator was the seizure-free rate over the three epochs. Using epoch 1 as a reference, we also compared the percentage of women with an increased seizure frequency, as well as changes in ASM treatment, in epochs 2 and 3. Ultimately, 271 eligible pregnancies in 249 women were included. The seizure-free rates in epoch 1, epoch 2, and epoch 3 were 38.4%, 34.7%, and 43.9%, respectively (P = 0.09). The top three ASMs used in the three epochs were lamotrigine, levetiracetam, and oxcarbazepine. Using epoch 1 as a reference, the percentages of women with increased frequencies of tonic‒clonic/focal to bilateral tonic‒clonic seizures in epoch 2 and epoch 3 were 17.0% and 14.8%, respectively, while the percentages of women with an increased frequency of non-tonic‒clonic seizures in epoch 2 and epoch 3 were 31.0% and 21.8% (P = 0.02). The percentage of women whose ASM dosages were increased in epoch 2 was higher than that in epoch 3 (35.8% vs. 27.3%, P = 0.03). The seizure frequency during pregnancy may not differ significantly from that during prepregnancy and postpregnancy if WWE are treated according to the guidelines." @default.
- W4378191182 created "2023-05-26" @default.
- W4378191182 creator A5000121146 @default.
- W4378191182 creator A5010479632 @default.
- W4378191182 creator A5016170913 @default.
- W4378191182 creator A5030346806 @default.
- W4378191182 creator A5031010282 @default.
- W4378191182 creator A5041755596 @default.
- W4378191182 creator A5043931979 @default.
- W4378191182 creator A5050869911 @default.
- W4378191182 creator A5053505116 @default.
- W4378191182 creator A5085685945 @default.
- W4378191182 date "2023-07-01" @default.
- W4378191182 modified "2023-10-18" @default.
- W4378191182 title "Changes in seizure frequency and anti-seizure medication therapy during pregnancy and one year postpregnancy" @default.
- W4378191182 cites W1560790036 @default.
- W4378191182 cites W1606704864 @default.
- W4378191182 cites W1974081766 @default.
- W4378191182 cites W1975223621 @default.
- W4378191182 cites W1978437325 @default.
- W4378191182 cites W1983142641 @default.
- W4378191182 cites W1991311905 @default.
- W4378191182 cites W2019602098 @default.
- W4378191182 cites W2036005775 @default.
- W4378191182 cites W2055414719 @default.
- W4378191182 cites W2059713508 @default.
- W4378191182 cites W2060118489 @default.
- W4378191182 cites W2061931974 @default.
- W4378191182 cites W2062997526 @default.
- W4378191182 cites W2065710966 @default.
- W4378191182 cites W2071820258 @default.
- W4378191182 cites W2079544599 @default.
- W4378191182 cites W2082892977 @default.
- W4378191182 cites W2088129118 @default.
- W4378191182 cites W2092006301 @default.
- W4378191182 cites W2099478180 @default.
- W4378191182 cites W2100288005 @default.
- W4378191182 cites W2105934200 @default.
- W4378191182 cites W2130104612 @default.
- W4378191182 cites W2130786458 @default.
- W4378191182 cites W2146775207 @default.
- W4378191182 cites W2150305604 @default.
- W4378191182 cites W2172263007 @default.
- W4378191182 cites W2298036133 @default.
- W4378191182 cites W2402079476 @default.
- W4378191182 cites W2563036039 @default.
- W4378191182 cites W2592509339 @default.
- W4378191182 cites W2593873339 @default.
- W4378191182 cites W2594644573 @default.
- W4378191182 cites W2769298480 @default.
- W4378191182 cites W2891262227 @default.
- W4378191182 cites W2892779570 @default.
- W4378191182 cites W2897525293 @default.
- W4378191182 cites W2921007674 @default.
- W4378191182 cites W2922176617 @default.
- W4378191182 cites W3113620641 @default.
- W4378191182 cites W4236676256 @default.
- W4378191182 cites W4239594659 @default.
- W4378191182 doi "https://doi.org/10.1016/j.yebeh.2023.109256" @default.
- W4378191182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37244219" @default.
- W4378191182 hasPublicationYear "2023" @default.
- W4378191182 type Work @default.
- W4378191182 citedByCount "0" @default.
- W4378191182 crossrefType "journal-article" @default.
- W4378191182 hasAuthorship W4378191182A5000121146 @default.
- W4378191182 hasAuthorship W4378191182A5010479632 @default.
- W4378191182 hasAuthorship W4378191182A5016170913 @default.
- W4378191182 hasAuthorship W4378191182A5030346806 @default.
- W4378191182 hasAuthorship W4378191182A5031010282 @default.
- W4378191182 hasAuthorship W4378191182A5041755596 @default.
- W4378191182 hasAuthorship W4378191182A5043931979 @default.
- W4378191182 hasAuthorship W4378191182A5050869911 @default.
- W4378191182 hasAuthorship W4378191182A5053505116 @default.
- W4378191182 hasAuthorship W4378191182A5085685945 @default.
- W4378191182 hasConcept C118552586 @default.
- W4378191182 hasConcept C121332964 @default.
- W4378191182 hasConcept C1276947 @default.
- W4378191182 hasConcept C150846664 @default.
- W4378191182 hasConcept C187212893 @default.
- W4378191182 hasConcept C2777332695 @default.
- W4378191182 hasConcept C2778186239 @default.
- W4378191182 hasConcept C2778802184 @default.
- W4378191182 hasConcept C2779234561 @default.
- W4378191182 hasConcept C2779253243 @default.
- W4378191182 hasConcept C2780317896 @default.
- W4378191182 hasConcept C2781176495 @default.
- W4378191182 hasConcept C42219234 @default.
- W4378191182 hasConcept C54355233 @default.
- W4378191182 hasConcept C71924100 @default.
- W4378191182 hasConcept C86803240 @default.
- W4378191182 hasConceptScore W4378191182C118552586 @default.
- W4378191182 hasConceptScore W4378191182C121332964 @default.
- W4378191182 hasConceptScore W4378191182C1276947 @default.
- W4378191182 hasConceptScore W4378191182C150846664 @default.
- W4378191182 hasConceptScore W4378191182C187212893 @default.
- W4378191182 hasConceptScore W4378191182C2777332695 @default.
- W4378191182 hasConceptScore W4378191182C2778186239 @default.
- W4378191182 hasConceptScore W4378191182C2778802184 @default.